2023年7月1日

巴里Faye院长,星期六,2023年7月1日,在月肿瘤学家新海德公园,纽约的Northwell健康开始使用iNav——人造intelligence-enabled与胰腺癌诊断工具内部开发——人们已经变得“连接到护理,天,如果不是周,早在他们关心轨迹”,丹尼尔·王,医学博士,博士,癌症研究学院的助理教授Northwell Feinstein学院医学研究在纽约,纽约对贝克。金博士和他的两个Northwell的同事——Sandeep Nadella,医学博士,北岸大学胃肠病学家医院在纽约,和蒂芙尼Zavadsky NP, RN - iNav技术开发,赢得Northwell 2023创新的挑战。iNav能够分析大量的CT和MRI扫描报告,每周超过10000腹部扫描,发现任何迹象的质量或病变病人的胰腺。它能够清除提到“没有明显的质量,”。著名的记录然后被称为通过iNav协调员证实胰腺质量的存在,需要检查。医疗体系在iNav计划投资500000美元,金博士表示将加快胰腺癌的诊断和治疗,没有人工智能技术,将被发现在后期的发展。事实上,它已经这么做的。一般来说,患者寻求医疗保健条件,使疼痛或其他症状;胰腺癌通常未被发现,直到后期,王博士说。 However, the scans patients get for those other conditions sometimes reveal pancreatic masses that went unaddressed. Dr. King described a particular case that underscores the importance and validity of iNav. A patient received a CT scan to confirm a kidney cyst after being seen by a urologist. The scan revealed the kidney cyst was benign, "which means the patient normally would have waited two weeks or more for a follow-up appointment with their physician," Dr. King said. However, this particular scan report noted something else: a 4-centimeter mass in the patient's pancreas. iNav was able to find that note in the patient's medical record and, after verifying the existence of the mass, the coordinator was able to refer the patient to Dr. King's team. Next steps, he said, are biopsy and continued care if necessary. Northwell Health has a multidisciplinary clinic dedicated to treating pancreatic cancer where patients are able to see a surgeon, medical oncologist, gastroenterologist and social worker. By bringing all of these services together, patients are connected to care faster. The earlier the disease is detected, "the more likely we'll catch it at a time that it can be removed and potentially cured," Dr. King said. Northwell Health is planning to sell the iNav technology to other healthcare systems, Richard Mulry, president and CEO of Northwell Holdings & Ventures, told Becker's. iNav could also bring Northwell a multimillion-dollar return on its $500,000 investment due to increased follow-up appointments made by pancreatic cancer patients.